Follow
'The flurry of retractions and corrections follows a major project in 2021 which found that researchers could reproduce results from only half of the top pre-clinical cancer studies they looked at. In many cases, when the experiments were repeated, any positive outcomes were far smaller than originally claimed. “Maybe part of that is because the work being done isn’t high quality,” David said. “It all eventually filters through to a lack of replicability.”
